Analyze Diet
Trends in endocrinology and metabolism: TEM1994; 5(1); 21-28; doi: 10.1016/1043-2760(94)90117-1

Animal models of Cushing’s disease.

Abstract: Cushing's disease, defined as hyperadrenocorticism resulting from excessive secretion of pituitary ACTH, occurs spontaneously and quite commonly in dogs and horses. In dogs, as in humans, the disease is usually associated with a small tumor of the pituitary pars distalis. However, the disease may arise occasionally (dogs) or exclusively (horses) from tumors or hyperplasia of the pituitary pars intermedia. In dogs, pars intermedia tumors may arise from one of two proopiomelanocortin-containing cell types that are present in normal tissue.
Publication Date: 1994-01-01 PubMed ID: 18407184DOI: 10.1016/1043-2760(94)90117-1Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates Cushing’s disease in animals, specifically dogs and horses, with a focus on how pituitary ACTH excessive secretion contributes to its occurrence and the role pituitary tumors play in the disease’s development.

Overview of Cushing’s Disease

  • Cushing’s disease, scientifically referred to as hyperadrenocorticism, is characterized by the overproduction of the hormone, adrenocorticotropic hormone (ACTH), produced in the pituitary gland.
  • The excess production of ACTH causes an increase in cortisol levels, a hormone that aids in managing stress and maintaining functions such as metabolism and immune response.
  • Observation in Animals

    • The researchers discovered that Cushing’s disease occurs naturally and quite often in animals, focusing their study mainly on dogs and horses.
    • The manifestation of the disease in these animals presents an opportunity to understand the disease further due to their higher occurrence rate as opposed to other species.
    • Role of Pituitary Tumours in Cushing’s Disease

      • Based on the research, in most instances, Cushing’s disease in dogs and humans is associated with a small tumor located in a part of the pituitary gland known as the pituitary pars distalis.
      • However, the disease can sometimes originate from tumors or an increase in the number or size of cells (hyperplasia) in another part of the pituitary gland, the pituitary pars intermedia – an area frequently affected in horses.
      • Cellular Origin of Pars Intermedia Tumours

        • In dogs, tumors in pars intermedia can emerge from either of the two cell types that contain proopiomelanocortin (POMC) present in the normal tissue. POMC is a precursor polypeptide with many biological functions, including the synthesis of ACTH.

Cite This Article

APA
Kemppainen RJ, E Peterson M. (1994). Animal models of Cushing’s disease. Trends Endocrinol Metab, 5(1), 21-28. https://doi.org/10.1016/1043-2760(94)90117-1

Publication

ISSN: 1043-2760
NlmUniqueID: 9001516
Country: United States
Language: English
Volume: 5
Issue: 1
Pages: 21-28

Researcher Affiliations

Kemppainen, R J
  • Robert J. Kemppainen is at the Department of Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA.
E Peterson, M

    Citations

    This article has been cited 5 times.
    1. Sieber-Ruckstuhl NS, Burla B, Spoerel S, Schmid F, Venzin C, Cazenave-Gassiot A, Bendt AK, Torta F, Wenk MR, Boretti FS. Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure. Sci Rep 2019 Apr 12;9(1):6015.
      doi: 10.1038/s41598-019-42190-1pubmed: 30979907google scholar: lookup
    2. Langlois DK, Fritz MC, Schall WD, Bari Olivier N, Smedley RC, Pearson PG, Bailie MB, Hunt SW 3rd. ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome. BMC Endocr Disord 2018 May 2;18(1):24.
      doi: 10.1186/s12902-018-0251-5pubmed: 29720169google scholar: lookup
    3. Fukuoka H, Cooper O, Ben-Shlomo A, Mamelak A, Ren SG, Bruyette D, Melmed S. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Invest 2011 Dec;121(12):4712-21.
      doi: 10.1172/JCI60417pubmed: 22105169google scholar: lookup
    4. de Bruin C, Hanson JM, Meij BP, Kooistra HS, Waaijers AM, Uitterlinden P, Lamberts SW, Hofland LJ. Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease. Endocrinology 2008 Sep;149(9):4357-66.
      doi: 10.1210/en.2008-0244pubmed: 18483151google scholar: lookup
    5. Massardi E, Gaudenzi G, Carra S, Oldani M, Rybinska I, Persani L, Vitale G. Cushing's Disease in the Animal Kingdom: Translational Insights for Human Medicine. Int J Mol Sci 2025 Sep 4;26(17).
      doi: 10.3390/ijms26178626pubmed: 40943544google scholar: lookup